Literature DB >> 16423002

Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction.

V de Francesco1, M Margiotta, A Zullo, C Hassan, N D Valle, O Burattini, U Cea, G Stoppino, A Amoruso, F Stella, S Morini, C Panella, E Ierardi.   

Abstract

BACKGROUND: Helicobacter pylori clarithromycin resistance is increasing worldwide and different mutations are involved in its mechanisms. Recently, molecular methods have been proposed to assess these mutations. AIM: To assess prevalence of primary clarithromycin resistance in two Italian areas, and the distribution of involved mutations, by using a novel method for real-time polymerase chain reaction.
METHODS: Two hundred and thirty-two H. pylori-positive patients undergoing oesophagogastroduodenoscopy in two Italian towns (Rome, centre Italy; Foggia, south Italy) were enrolled. Helicobacter pylori infection was detected by histology, rapid urease and urea breath tests. Clarithromycin resistance was assessed by TaqMan real-time polymerase chain reaction on paraffin-embedded antral biopsies. Results Primary clarithromycin resistance was detected in 62 (26.7%) patients. Its prevalence did not differ between the two areas (31.5%, centre vs. 23.3%, south; P=0.17) and between non-ulcer dyspepsia and peptic ulcer patients (28.4% vs. 20.7%, P=0.2). The A2143G point mutation was detected in 35 (56.4%) patients, A2142G in 14 (22.6%), A2142C in eight (12.9%), whilst a double mutation (A2143G plus A2142C or A2142G) was present in the remaining five (8.1%) cases.
CONCLUSIONS: Our study found that primary clarithromycin resistance is highly prevalent in both central and southern Italy, and that A2143G is the most frequent point mutation involved in these areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423002     DOI: 10.1111/j.1365-2036.2006.02769.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

1.  Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.

Authors:  Xiao-Feng Luo; Jian-Hua Jiao; Wen-Yue Zhang; Han-Ming Pu; Bao-Jin Qu; Bing-Ya Yang; Min Hou; Min-Jun Ji
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.

Authors:  V Y Miendje Deyi; V Y Miendje Deyi; P Bontems; J Vanderpas; E De Koster; R Ntounda; C Van den Borre; S Cadranel; A Burette
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

3.  Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy.

Authors:  Hasyanee Binmaeil; Alfizah Hanafiah; Isa Mohamed Rose; Raja Affendi Raja Ali
Journal:  Infect Drug Resist       Date:  2021-10-06       Impact factor: 4.003

4.  Evaluation for Helicobacter pylori in Meckel's diverticulum by using real-time PCR.

Authors:  Ahmet Tuzun; Zulfikar Polat; Guldem Kilciler; Ilker Turan; Abdullah Kilic; Ayhan Ozcan; Ahmet Uygun
Journal:  Dig Dis Sci       Date:  2009-08-29       Impact factor: 3.199

5.  Prevalence of Helicobacter pylori infection and the incidence of ureA and clarithromycin resistance gene 23S rRNA genotypes status in Saudi Arabia.

Authors:  Marwah M Bakri
Journal:  Saudi J Biol Sci       Date:  2012-11-16       Impact factor: 4.219

6.  Helicobacter pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years.

Authors:  Vincenzo De Francesco; Marcella Margiotta; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Mariangela Zotti; Giuseppe Stoppino; Alessia Bastianelli; Francesco Diterlizzi; Giovanna Verderosa; Sergio Morini; Carmine Panella; Enzo Ierardi
Journal:  Dig Dis Sci       Date:  2008-07-03       Impact factor: 3.199

Review 7.  The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.

Authors:  Angelo Zullo; Vincenzo De Francesco; Cesare Hassan; Sergio Morini; Dino Vaira
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

8.  Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?

Authors:  Floriana Giorgio; Mariabeatrice Principi; Vincenzo De Francesco; Angelo Zullo; Giuseppe Losurdo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-08-15

9.  Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.

Authors:  Cesare Efrati; Giorgia Nicolini; Claudio Cannaviello; Nicole Piazza O'Sed; Stefano Valabrega
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

10.  Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H. pylori eradication success.

Authors:  Carlo-Federico Zambon; Michela Fasolo; Daniela Basso; Anna D'Odorico; Alessia Stranges; Filippo Navaglia; Paola Fogar; Eliana Greco; Stefania Schiavon; Andrea Padoan; Elisa Fadi; Giacomo Carlo Sturniolo; Mario Plebani; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2007-09-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.